Boston, MA –(ENEWSPF)–June 12, 2017. Stress, increased risk for disease, babies born too early, and premature death are among the negative health impacts that could occur in the wake of the 2016 U.S. presidential election, according to a new article from Harvard T.H. Chan School of Public Health and Massachusetts[Read More…]
Science
Roosevelt University’s President Ali Malekzadeh Signs Letter of Support for Paris Climate Accord
CHICAGO–(ENEWSPF)–June 12, 2017 Roosevelt University recognizes our responsibility to the environment. Despite President Trump’s withdrawal last week of the U.S. from the Paris Agreements, we reaffirm our commitment to national and global cooperation for a sustainable future. Today I joined nearly 200 presidents of colleges and universities – and over a[Read More…]
Updated CDC Travel Health Book Now Online
2018 Yellow Book includes important health information for international travel Atlanta, GA–(ENEWSPF)–June 12, 2017. CDC’s 2018 Yellow Book, the definitive guide for healthy international travel, is now available for free online and for order in hard copy. The 2018 edition features significant revisions, updates to important travel health recommendations, new[Read More…]
Mayor Emanuel Announces 12 Other Cities Join Chicago to Publish EPA Climate Change Information
CHICAGO–(ENEWSPF)–June 12, 2017. Mayor Rahm Emanuel today announced that 12 other cities have joined the City of Chicago in posting research from the U.S. Environmental Protection Agency’s (EPA) Climate Change Website after the Trump administration unceremoniously removed it from the federal government’s websites on April 29. “It is inspiring to[Read More…]
FDA Issues Nationwide Recall of Certain Birth Control Pills
Baltimore, Maryland–(ENEWSPF)–June 12, 2017. Lupin Pharmaceuticals Inc. announced today that it has voluntarily recalled lot L600518, Exp 05/18 of Mibelas 24 Fe A confirmed market complaint indicated a packaging error, where the blister was rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number[Read More…]
NIAID Scientists Discover Rare Genetic Susceptibility to Common Cold
Unusual case provides insight into leading cause of acute illness worldwide. Bethesda, Maryland–(ENEWSPF)–June 12, 2017. Scientists have identified a rare genetic mutation that results in a markedly increased susceptibility to infection by human rhinoviruses (HRVs) — the main causes of the common cold. Colds contribute to more than 18 billion[Read More…]
Trump Administration Pushes Coal Mining in Roadless Forest in Colorado
Forest Service Pushes to Mine Next to West Elk Wilderness, Giving Arch Coal Access to More Than 17 Million Tons of Coal DENVER—(ENEWSPF)–June 9, 2017. Just days after announcing the U.S. will exit the Paris climate agreement, the Trump administration yesterday pushed ahead with plans for another damaging action: a[Read More…]
Study: Cannabis Extracts Associated With Reduced ADHD Symptoms
London, United Kingdom–(ENEWSPF)–June 8, 2017. The administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with Attention Deficit Hyperactivity Disorder (ADHD), according to clinical trial data published online ahead of print in the journal European Neuropsychopharmacology. British scientists conducted a randomized, placebo-controlled trial evaluating[Read More…]
Lost Ecosystem Found Buried in Mud of Southern California Coastal Waters
Geological methods provide insights into recent ecological transitions Shells from muddy sediment collected on the western Palos Verdes shelf off the coast of southern California. The shells are from the scallop Chlamys hastata. Courtesy of: Prof. Susan Kidwell CHICAGO–(ENEWSPF)–June 8, 2017 By: Steve Koppes Paleontologists investigating the sea bed off[Read More…]
FDA Requests Removal of Opana ER for Risks Related to Opiod Abuse
Silver Spring, Maryland–(ENEWSPF)–June 8, 2017. Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer[Read More…]
